Developing a national registry of pharmacologic and biologic clinical trials : workshop report / Committee on Clinical Trial Registries, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Includes bibliographical references (pages 47-48).

Print version record.

Use copy Restrictions unspecified star MiAaHDL

Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2010. MiAaHDL

Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. MiAaHDL

http://purl.oclc.org/DLF/benchrepro0212

digitized 2010 HathiTrust Digital Library committed to preserve pda MiAaHDL

FrontMatter -- Independent Report Reviewers -- Foreword -- Preface -- Contents -- List of Tables -- 1 Summary -- 2 The Need for Clinical Trial Registries -- 3 Current Registry Activities -- 4 Content of a Clinical Trial Registry -- 5 Implementation Issues -- 6 Conclusion and Next Steps -- References -- APPENDIXES -- A Participants and Invited Experts Between December 1, 2004, and June 27, 2005 -- B Workshop Agenda, Speakers, Panelists, and Participants: June 27, 2005

C Section 113 of the Food and Drug Administration Modernization Act of 1997 and Guidance for Industry: Information Programs on Clinical Trials for Serious or Life- Threatening Diseases and Conditions. U.S. Department of Health and Human Services.D Published Journal Editorials -- E Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases -- F Illustrative Data Fields for the Results Summary (based on ICH E3 template) -- G Biographical Sketches of Committee Members

English.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide